טוען...
Nephrogenic Systemic Fibrosis in Liver Disease: A Systematic Review
Nephrogenic systemic fibrosis may develop in patients with liver disease, a fact highlighted by recent FDA announcements cautioning against the use of gadolinium-based contrast agents (GBCAs) in select liver disease patients. The purpose of this systematic literature review is to characterize the ri...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2009
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2844250/ https://ncbi.nlm.nih.gov/pubmed/19937937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.21983 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|